KemPharm, Inc. (KMPH) insiders have most recently took part in a trading activity. On Aug 24, 2017 Cohen Daniel L, EVP, Govt. & Public Relations bought 5,000 shares having total worth of $12,900 at the price of $2.58 per share, following the transaction a total of 25,000 shares owned by Cohen Daniel L. Before this latest buy, Cohen Daniel L purchased KMPH at 4 other times during the past twelve months, for a total investment of $86,475 at an average of $4.21 per share.
On the same day, Johnson Gordon K, Chief Business Officer bought 4,000 shares having total worth of $10,400 at the price of $2.6 per share, following the transaction a total of 6,000 shares owned by Johnson Gordon K.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 10 times by insiders. an employee of the company was the buyer in 10 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of KemPharm, Inc. (KMPH) traded up 3.92% on Aug 24, 2017, hitting $2.65. 36,020 shares of the company’s stock traded hands. KemPharm, Inc. has a 52 week low of $2.55 and a 52 week high of $18.68. The company’s market cap is $65 million.
KemPharm, Inc. (KMPH) last announced its earnings results on Aug 10, 2017. The company reported -0.44 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.63 by $0.19. During the same quarter in the previous year, the company posted -0.58 earnings per share.
|earnings per share||-0.44||-0.84||-0.68||-0.92||-0.58||0.12||-0.64||-0.68||-2.45||-2.50|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018